Alpha Biotech

ALPHA Biotech offers a structured support program built around three complementary pillars to help startups at TRL 4–8 successfully reach industrial deployment.

The program has already demonstrated impact through a 2025 pilot phase.

Verbatim « Having all these stakeholders regularly mobilized around our project saved us a significant amount of time and clearly contributed to our decision to establish operations in the Grand Est. »

Céline Domerc, Co-Founder, AgriLab Leverage

By joining ALPHA Biotech, you can:

✔ Reduce technological and industrial risks

✔ Access real industrial-scale infrastructure

✔ Build a credible financing roadmap

✔ Secure market opportunities and industrial off-take

✔ Strengthen your positioning with investors

✔ Integrate into a structured and active industrial ecosystem

Selected startups benefit from tailored support designed to secure their industrial scale-up.

1. De-risk your technology & industrial scale-Up

Master your transition to industrial scale with coordinated scientific and industrial support:

• Access regional labs, pilot units and demonstration facilities

• Optimize bioprocesses and prepare for industrial scaling

• Leverage CEBB (TRL 2–5) and ARD (TRL 6–9) expertise

• Benefit from regulatory guidance and connect with regional industrial partners

Objective: secure your technology and ensure industrial robustness.

2. Structure & finance your industrial growth

Strengthen your business and financial trajectory:

• Refine your business model and development strategy

• Build a solid financial engineering roadmap

• Identify and combine relevant public and private funding

• Receive support for fundraising

• Connect with specialized biotech investors

• Access monitoring of national and European funding calls

Objective: secure financing for key development milestones.

3. Accelerate Market Deployment & Territorial Anchoring

Grow your company within a leading industrial bioeconomy cluster:

• Structure your market access and commercial strategy

• Connect with industrial partners and value chains

• Receive support for site selection and regional establishment

• Access regional investment and innovation schemes

• Benefit from local biomass availability and strategic resources

Objective: anchor your project in a structured industrial environment that supports long-term growth.

Please note: ALPHA Biotech does not provide direct financial grants.
However, it facilitates access to and optimization of public and private funding instruments.

ALPHA Biotech targets startups and innovative young companies in industrial biotechnology aiming to industrialize and develop operations in the Grand Est Region.

Eligible companies :

• Incorporated startups

• Based in France or internationally

Technology scope

• Bioprocesses and industrial fermentation

• Bio-based chemistry and enzymes

• Biomass valorization and co-products

• Applications in agri-food, energy, materials, chemicals, cosmetics or health (excluding regulated medical biotechnologies)

*non-exhaustive list

Expected maturity level

• TRL 4 to 8

• Validated proof of concept

• Identified need for industrial scale-up or pre-industrial demonstration

Projects will be evaluated based on:

• Technological innovation and differentiation

• Technical maturity and scalability potential

• Market potential and techno-economic viability

• Economic and environmental impact

• Credibility of the regional implementation strategy

Application deadline: May 31, 2026. Submit a pitch deck including:

• Un plan d’affaires

• R&D roadmap

• Strategy for establishment or expansion in the Grand Est Region

Applications via: airtable.com

Full confidentiality guaranteed throughout the program and for three years after its completion.

• May 31, 2026 : Application deadline

• Early June : Application review

• Mid-June : Project hearings

• June 17–20 : Official announcement of selected startups at VivaTech

• September 2026 : Program start